AETNA INC /PA/ | 2013 | FY | 3


The stock-based compensation awards excluded from the calculation of diluted EPS for 2013, 2012 and 2011 are as follows:
(Millions)
2013

 
2012

 
2011

Stock appreciation rights ("SARs") (1)
1.7

 
8.3

 
12.4

Market stock units ("MSUs") (2)
.4

 
.2

 

Performance stock units ("PSUs") (2)
.7

 
.5

 
.3

Performance stock appreciation rights ("PSARs") (2)
.7

 

 

 
 
 
 
 
 
(1) 
SARs are excluded from the calculation of diluted EPS if the exercise price is greater than the average market price of Aetna common shares during the period (i.e., the awards are anti-dilutive).
(2) 
PSUs, certain MSUs with performance conditions, and PSARs are excluded from the calculation of diluted EPS if all necessary performance conditions have not been satisfied at the end of the reporting period (refer to Note 12 beginning on page 121 for additional information about PSARs).

us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock